PARTIAL ECONOMIC EVALUATION |
Cost of illness analysis |
Disease economic burden |
Net cost ($) |
Public health decision-makers at the local, state, and national levels |
Program cost analysis |
Net program cost |
Net cost ($) |
Public health decision-makers at the local, state, and national levels |
|
|
|
First step to CEA, CUA, and CBA |
FULL ECONOMIC EVALUATION |
Cost-benefit analysis (CBA) |
Compares different programs with different outcomes (e.g., health vs. other area) |
Benefit-cost ratio ($benefit: $cost) |
National level and broader perspective, such as the President and Congress (e.g.,: Congress needs to decide between investments in health or investments for another program) |
Cost-effectiveness analysis (CEA) |
Compares interventions with the same outcomes (ex: between two cervical cancer interventions) |
Cost-effectiveness ratio ($per case averted) |
Program level (ex: a cancer program director decides to fund one of two possible cervical cancer prevention interventions) |
Cost utility analysis (CUA) |
Compares interventions with different health outcomes (ex: cervical cancer vs. Alzheimer’s disease) |
Cost-utility ratio ($per QALY saved) |
Agency level (ex: the CDC or a local health agency director decides between funding cervical cancer or Alzheimer’s disease interventions) |